# Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

> **NCT02006745** · PHASE3 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 20 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Ribavirin
- **DRUG:** Telaprevir

## Key facts

- **NCT ID:** NCT02006745
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006745, "Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02006745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*